Belpointe Asset Management’s Hims & Hers Health HIMS Stock Holding History

Belpointe Asset Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$607K	Buy	+17,501	New	+$470K	0.02%	653
2025 Q4	–	Sell	-19,569	Closed	-$1.11M	–	1061
2025 Q3	$1.11M	Buy	19,569 +14,824	+312%	+$760K	0.04%	371
2025 Q2	$237K	Sell	4,745 -2,878	-38%	-$130K	0.01%	823
2025 Q1	$225K	Sell	7,623 -7,514	-50%	-$279K	0.01%	820
2024 Q4	$223K	Sell	15,137 -18	-0.1%	-$446	0.01%	775
2024 Q3	$279K	Buy	15,155 +2,859	+23%	+$51.2K	0.02%	688
2024 Q2	$248K	Sell	12,296 -1,501	-11%	-$25K	0.02%	651
2024 Q1	$213K	Buy	13,797 +559	+4%	+$6.3K	0.02%	721
2023 Q4	$118K	Buy	13,238 +1,205	+10%	+$8.91K	0.01%	686
2023 Q3	$75.7K	Buy	+12,033	New	+$89.5K	0.01%	636
2023 Q2	–	Sell	-4,643	Closed	-$46.1K	–	1752
2023 Q1	$46.1K	Buy	+4,643	New	+$40.7K	﹤0.01%	1749

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Belpointe Asset Management's HIMS Position: Q2 2026 in Review

Belpointe Asset Management opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 17,501 shares worth $607K. The stake represents 0.02% of the portfolio and ranks #653 among its holdings. This is a return to the name: Belpointe Asset Management previously reported a position in HIMS as recently as Q3 2025.

Belpointe Asset Management first reported a position in HIMS in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.11M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Belpointe Asset Management held 17,501 shares of Hims & Hers Health worth $607K as of Q2 2026.
Hims & Hers Health was a new Belpointe Asset Management position in Q2 2026.
Hims & Hers Health made up 0.02% of Belpointe Asset Management's portfolio in Q2 2026, its #653 holding.
Belpointe Asset Management first reported a position in Hims & Hers Health in Q1 2023 and has held it in 11 quarters since.
Belpointe Asset Management's Hims & Hers Health position peaked at $1.11M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.